HomePGEN • NASDAQ
Precigen Inc
add
$1.45
10.69%
After Hours:(0.00%)0.00
$1.45
Closed: May 16, 4:02:29 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.34M | 25.92% |
Operating expense | 22.84M | -6.41% |
Net income | -54.15M | -128.13% |
Net profit margin | -4.04K | -81.18% |
Earnings per share | -0.18 | -80.00% |
EBITDA | -21.97M | 3.72% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 80.24M | 79.28% |
Total assets | 128.79M | -4.49% |
Total liabilities | 142.85M | 277.62% |
Total equity | -14.06M | — |
Shares outstanding | 295.18M | — |
Price to book | -26.20 | — |
Return on assets | -41.23% | — |
Return on capital | -319.40% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -54.15M | -128.13% |
Cash from operations | -16.33M | -15.86% |
Cash from investing | -6.46M | -126.85% |
Cash from financing | -679.00K | — |
Net change in cash | -23.46M | -337.08% |
Free cash flow | -8.27M | -1.87% |
Previous close
$1.31
Day range
$1.31 - $1.53
Year range
$0.65 - $2.17
Market cap
428.01M USD
Avg Volume
1.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
143
